The SGLT2 inhibitors simultaneously lowered both insulin toxicity and glucotoxicity, and the results were nothing short of amazing. Weight loss is one of the most noticeable side benefits of this class of medication. Not only did patients lose weight, unlike virtually every other dietary trial, they kept the weight off even after the two years.
